Weekly insulin Efsitora Alpha effective in type 2 diabetes – more frequent…

medicine Friday, September 13, 2024 Indianapolis – In addition to Novo Nordisk, which recently received approval for insulin Icodec in Europe, its competitor Lilly also wants to introduce an ultra-long-acting insulin that allows once-weekly dosing.